Works matching IS 00912700 AND DT 2014 AND VI 54 AND IP 8

Results: 17

Clopidogrel: What Is a Cardiologist to Do?

Published in:

Journal of Clinical Pharmacology, 2014, v. 54, n. 8, p. 881, doi. 10.1002/jcph.330

By:

Ford, Neville F.

Publication type:

Article

The influence of genetic polymorphism of Cyp2c19 isoenzyme on the pharmacokinetics of clopidogrel and its metabolites in patients with cardiovascular diseases.

Published in:

Journal of Clinical Pharmacology, 2014, v. 54, n. 8, p. 874, doi. 10.1002/jcph.323

By:

Karaźniewicz‐Łada, Marta;
Danielak, Dorota;
Rubiś, Błażej;
Burchardt, Paweł;
Oszkinis, Grzegorz;
Główka, Franciszek

Publication type:

Article

The association of proton pump inhibitors and hypomagnesemia in the community setting.

Published in:

Journal of Clinical Pharmacology, 2014, v. 54, n. 8, p. 889, doi. 10.1002/jcph.316

By:

Markovits, Noa;
Loebstein, Ronen;
Halkin, Hillel;
Bialik, Martin;
Landes‐Westerman, Janet;
Lomnicky, Joseph;
Kurnik, Daniel

Publication type:

Article

Population pharmacokinetics of the 5-hydroxymethyl metabolite of tolterodine after administration of fesoterodine sustained release tablet in western and east Asian populations.

Published in:

Journal of Clinical Pharmacology, 2014, v. 54, n. 8, p. 928, doi. 10.1002/jcph.274

By:

Oishi, Masayo;
Tomono, Yoshiro;
Yamagami, Hidetomi;
Malhotra, Bimal

Publication type:

Article

Positive clinical response to clopidogrel is independent of paraoxonase 1 Q192R and CYP2C19 genetic variants.

Published in:

Journal of Clinical Pharmacology, 2014, v. 54, n. 8, p. 843, doi. 10.1002/jcph.275

By:

Martínez-Quintana, Efrén;
Medina-Gil, José M;
Rodríguez-González, Fayna;
Garay-Sánchez, Paloma;
Limiñana, José M;
Saavedra, Pedro;
Tugores, Antonio

Publication type:

Article

Modeling and simulation of bone mineral density response from a phase 2 study of ONO-5334, a new cathepsin K inhibitor, to support dose selection in osteoporosis.

Published in:

Journal of Clinical Pharmacology, 2014, v. 54, n. 8, p. 937, doi. 10.1002/jcph.279

By:

Hasegawa, Chihiro;
Kastrissios, Helen;
Monteleone, Jonathan;
Ohno, Tomoya;
Umemura, Takeo;
Ohyama, Michiyo;
Nagase, Shinichi;
Small, Maria;
Deacon, Steve;
Ogawa, Mikio;
Ieiri, Ichiro

Publication type:

Article

The clopidogrel conundrum.

Published in:

Journal of Clinical Pharmacology, 2014, v. 54, n. 8, p. 841, doi. 10.1002/jcph.344

By:

Bertino, Joseph S.

Publication type:

Article

Clopidogrel, CYP2C19 and proton pump inhibitors: What we know and what it means.

Published in:

Journal of Clinical Pharmacology, 2014, v. 54, n. 8, p. 884, doi. 10.1002/jcph.337

By:

Hariharan, Sudharshan;
Southworth, Mary Ross;
Madabushi, Rajanikanth

Publication type:

Article

Effectiveness of clopidogrel dose escalation to normalize active metabolite exposure and antiplatelet effects in CYP2C19 poor metabolizers.

Published in:

Journal of Clinical Pharmacology, 2014, v. 54, n. 8, p. 865, doi. 10.1002/jcph.293

By:

Horenstein, Richard B.;
Madabushi, Rajnikanth;
Zineh, Issam;
Yerges‐Armstrong, Laura M.;
Peer, Cody J.;
Schuck, Robert N.;
Figg, William Douglas;
Shuldiner, Alan R.;
Pacanowski, Michael A.

Publication type:

Article

Identification of VKORC1 genotype leading to resistance to tecarfarin.

Published in:

Journal of Clinical Pharmacology, 2014, v. 54, n. 8, p. 896, doi. 10.1002/jcph.332

By:

Matagrin, Benjamin;
Montagut‐Romans, Adrien;
Damin, Marlene;
Lemaire, Marc;
Popowycz, Florence;
Benoit, Etienne;
Lattard, Virginie

Publication type:

Article

Issue Information.

Published in:: Journal of Clinical Pharmacology, 2014, v. 54, n. 8, p. i, doi. 10.1002/jcph.358
Publication type:: Article

Prevention of gastric mucosal injury induced by anti-platelet drugs by famotidine.

Published in:

Journal of Clinical Pharmacology, 2014, v. 54, n. 8, p. 858, doi. 10.1002/jcph.284

By:

Uotani, Takahiro;
Sugimoto, Mitsushige;
Nishino, Masafumi;
Ichikawa, Hitomi;
Sahara, Shu;
Yamade, Mihoko;
Iwaizumi, Moriya;
Yamada, Takanori;
Osawa, Satoshi;
Sugimoto, Ken;
Umemura, Kazuo;
Watanabe, Hiroshi;
Miyajima, Hiroaki;
Furuta, Takahisa

Publication type:

Article

Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with non-valvular atrial fibrillation: Results from ROCKET AF.

Published in:

Journal of Clinical Pharmacology, 2014, v. 54, n. 8, p. 917, doi. 10.1002/jcph.288

By:

Girgis, I.G.;
Patel, M.R.;
Peters, G.R.;
Moore, K.T.;
Mahaffey, K.W.;
Nessel, C.C.;
Halperin, J.L.;
Califf, R.M.;
Fox, K.A.A.;
Becker, R.C.

Publication type:

Article

An evaluation of oral dabigatran etexilate pharmacokinetics and pharmacodynamics in hemodialysis.

Published in:

Journal of Clinical Pharmacology, 2014, v. 54, n. 8, p. 901, doi. 10.1002/jcph.335

By:

Wilson, Jo‐Anne S.;
Goralski, Kerry B.;
Soroka, Steven D.;
Morrison, Matthew;
Mossop, Paula;
Sleno, Lekha;
Wang, Yan;
Anderson, David R.

Publication type:

Article

Population pharmacokinetic-pharmacodynamic modeling analysis of intrinsic FXa and bleeding from edoxaban treatment.

Published in:

Journal of Clinical Pharmacology, 2014, v. 54, n. 8, p. 910, doi. 10.1002/jcph.306

By:

Song, SaeHeum;
Kang, Dongwoo;
Halim, Abdel‐Baset;
Miller, Raymond

Publication type:

Article

The effect of CYP2C19 genotype on the time course of platelet aggregation inhibition after clopidogrel administration.

Published in:

Journal of Clinical Pharmacology, 2014, v. 54, n. 8, p. 850, doi. 10.1002/jcph.225

By:

Kim, Ho‐Sook;
Cho, Doo‐Yeoun;
Park, Bo‐Min;
Bae, Soo‐Kyoung;
Yoon, Yune‐Jung;
Oh, Minkyung;
Ghim, Jong‐lyul;
Kim, Eun‐Young;
Kim, Dong‐Hyun;
Shin, Jae‐Gook

Publication type:

Article

Pharmacokinetics of darunavir in fixed-dose combination with cobicistat compared with coadministration of darunavir and ritonavir as single agents in healthy volunteers.

Published in:

Journal of Clinical Pharmacology, 2014, v. 54, n. 8, p. 949, doi. 10.1002/jcph.290

By:

Kakuda, Thomas N.;
Opsomer, Magda;
Timmers, Maarten;
Iterbeke, Koen;
Van De Casteele, Tom;
Hillewaert, Vera;
Petrovic, Romana;
Hoetelmans, Richard M. W.

Publication type:

Article